Clinical practice guideline demonstrates evidence-based recommendations for biologics and JAK inhibitors in atopic dermatitis, highlighting optimized patient-tailored systemic therapies.
KADA's updated AD treatment guidelines incorporate the latest evidence and expert opinion to provide a comprehensive approach to AD treatment. The guidelines will help clinicians optimize patient-specific therapies.
No takes yet. Share an insight, caveat, or question.
Ko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: